BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22481199)

  • 1. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important cutaneous manifestations of inflammatory bowel disease.
    Trost LB; McDonnell JK
    Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucocutaneous manifestations of inflammatory bowel disease in Turkey.
    Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M
    J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: skin complications associated with inflammatory bowel disease.
    Tavarela Veloso F
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatological signs during inflammatory bowel diseases.
    Feliciani C; De Simone C; Amerio P
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():15-21. PubMed ID: 19530507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
    Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM
    Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous manifestations of ulcerative colitis].
    Areias E; Garcia e Silva L
    Med Cutan Ibero Lat Am; 1987; 15(3):185-97. PubMed ID: 3312861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis].
    Tian Y; Li JX; Wang HH; Li RY; Liu XG
    Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):505-9. PubMed ID: 27373283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin manifestations of inflammatory diseases of the gastrointestinal tract].
    Piette F; Colombel JF; Delaporte E
    Ann Dermatol Venereol; 1992; 119(4):297-306. PubMed ID: 1530244
    [No Abstract]   [Full Text] [Related]  

  • 20. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
    Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M;
    PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.